Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients

E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027

Article Information

doi 
https://doi.org/10.1101/2020.05.04.20090027
History 
  • May 8, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. E Tuaillon1,*,
  2. K Bolloré2,
  3. A Pisoni1,
  4. S Debiesse2,
  5. C Renault2,
  6. S Marie3,
  7. C Soraya3,
  8. C Niels3,
  9. N Pansu3,
  10. D Morquin3,
  11. V Foulongne1,
  12. A Bourdin3,
  13. V Le Moing3 and
  14. P Van de Perre1
  1. 1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
  2. 2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
  3. 3Montpellier University Hospital, Montpellier, France.
  1. ↵*Corresponding author: e-tuaillon{at}chu-montpellier.fr
Back to top
Posted May 08, 2020.
Download PDF
Data/Code
Email
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area